Works matching IS 11738804 AND DT 2020 AND VI 34 AND IP 1


Results: 9
    1
    2

    Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study.

    Published in:
    BioDrugs, 2020, v. 34, n. 1, p. 99, doi. 10.1007/s40259-019-00396-9
    By:
    • Kim, Yaerim;
    • Park, Su-Kil;
    • Cho, Won Yong;
    • Joo, Kwon Wook;
    • Shin, Sug Kyun;
    • Kim, Dae Joong;
    • Kim, Yong-Lim;
    • Son, Sung Hyun;
    • Chung, Wookyung;
    • Lee, Kwang Young;
    • Park, Sung Kwang;
    • Kim, Joong Kyung;
    • Kim, Soo Wan;
    • Kang, Duk-Hee;
    • Kim, Jin Kuk;
    • Jeon, Jin Seok;
    • Lee, Kang Wook;
    • Lee, Chang Hwa;
    • Oh, Dong-Jin;
    • An, Won Suk
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.

    Published in:
    BioDrugs, 2020, v. 34, n. 1, p. 55, doi. 10.1007/s40259-019-00385-y
    By:
    • Ingrasciotta, Ylenia;
    • Belleudi, Valeria;
    • Trotta, Francesco;
    • Addis, Antonio;
    • Fontana, Andrea;
    • Chinellato, Alessandro;
    • Ientile, Valentina;
    • Tari, Daniele Ugo;
    • Roberto, Giuseppe;
    • Pastorello, Maurizio;
    • Scondotto, Salvatore;
    • Cananzi, Pasquale;
    • Traversa, Giuseppe;
    • Davoli, Marina;
    • Rossi, Mariangela;
    • Trifirò, Gianluca;
    • On behalf of the Italian Biosimilars Network (I-BioNetwork);
    • Caputi, Achille P.;
    • Bolcato, Jenny;
    • Pirolo, Roberta
    Publication type:
    Article